Too early to say, “no targeting of mitosis!”

state that many mitotic inhibitors have been unsuccessful in clinical trials in patients with cancer, and conclude that targeting the mitotic process is not useful. While current drugs predominantly target microtubule proteins, targeting other proteins involved in mitosis is in its infancy. Inhibitors of only three (all kinases) of more than 100 mitotic proteins